BUENA, N.J., Sept. 19, 2017 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company’s ...

Teligent Inc (NASDAQ: TLGT), a specialty generic pharmaceutical firm, revealed Monday that it got the FDA approval for its abbreviated new drug application (ANDA) of Triamcinolone Acetonide Ointment ...

It is the generic version of Delcor Asset Corporation’s Kenalog cream Glenmark Pharmaceuticals, US has been granted final approval by the United States Food & Drug Administration (US FDA) for ...

Teligent announced that the Food and Drug Administration (FDA) has approved Triamcinolone Acetonide Ointment, 0.1%. Triamcinolone Acetonide Ointment is a topical steroid indicated for the relief of ...

Glenmark Pharmaceuticals Ltd has informed BSE regarding a Press Release dated August 08, 2016 titled "Glenmark Pharmaceuticals receives ANDA approval for Triamcinolone Acetonide Cream USP, 0.1%".

New Delhi, Aug 8: Glenmark Pharmaceuticals has received final nod from the US health regulator for generic Triamcinolone acetonide cream used for reducing itching, redness and swelling on skin.

The product is the generic equivalent of nystatin and triamcinolone acetonide cream, USP 1,00,000 units/g-0.1 per cent manufactured by Taro Pharmaceuticals USA Inc, it added. The product is the ...

With reference to the subject mentioned above, kindly find attached media release which is self-explanatory. Request you to kindly take the same on record. Advisory Alert: It has come to our attention ...

Alembic Pharmaceuticals Limited (Alembic) today announced that its joint venture Aleor Dermaceuticals Limited (Aleor) has received final approval from the US Food & Drug Administration (USFDA) for its ...

Share price of Glenmark Pharma gained nearly 2 percent intraday Wednesday on USFDA approval. Glenmark Pharmaceuticals Inc., USA has been granted final approval by the United States Food & Drug ...

* Teligent inc - ‍ expect to launch triamcinolone acetonide cream USP, 0.1% in Q4 of 2017 Source text for Eikon: Further company coverage: ...